Inventor · disambiguated record
Feng Chen
Also filed as: CHEN FENG · CHEN FENG-WEI
8 granted patents·14 pending applications·64 citations·filing 2001–2023
85Inventor score
Top patents by PatentIndex Score
22 records- 0194US8940272B2Human anti-tau antibodiesNITSCH ROGER·Filed 2011·Granted Jan 27, 2015·31 cites·9 claims
- 0293US9598484B2Human anti-tau antibodiesBIOGEN MA INC·Filed 2013·Granted Mar 21, 2017·18 cites·182 claims
- 0390US9605059B2Human anti-tau antibodiesBIOGEN INT NEUROSCIENCE GMBH·Filed 2014·Granted Mar 28, 2017·12 cites·70 claims
- 0478US10882902B2Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereofNEURIMMUNE HOLDING AG·Filed 2018·Granted Jan 5, 2021·1 cites·16 claims
- 0576US2025215492A1Preparation of long read nucleic acid librariesILLUMINA INC·Filed 2023·Application pending·0 cites
- 0676US2025327063A1Preparation of long read nucleic acid librariesILLUMINA INC·Filed 2023·Application pending·0 cites
- 0776US2025327064A1Preparation of long read nucleic acid librariesILLUMINA INC·Filed 2023·Application pending·0 cites
- 0873US2021238265A1Human Anti-Tau AntibodiesBIOGEN INT NEUROSCIENCE GMBH·Filed 2020·Application pending·0 cites
- 0972US2020262895A1Human anti-tau antibodiesBIOGEN MA INC·Filed 2019·Application pending·0 cites
- 1071US10072074B2Human islet amyloid polypeptide (HIAPP) specific antibodies and uses thereofNEURIMMUNE HOLDING AG·Filed 2016·Granted Sep 11, 2018·1 cites·26 claims
- 1169US9475866B2Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereofNEURIMMUNE HOLDING AG·Filed 2013·Granted Oct 25, 2016·1 cites·22 claims
- 1267US2021107972A1Human islet amyloid polypeptide (hiapp) specific antibodies and uses thereofNEURIMMUNE HOLDING AG·Filed 2020·Application pending·0 cites
- 1363US2019233506A1Human Anti-Tau AntibodiesBIOGEN INT NEUROSCIENCE GMBH·Filed 2018·Application pending·0 cites
- 1461US7550648B2Inducing neurofibrillary tangles in transgenic mice expressing a mutant tau proteinUNIV ZUERICH·Filed 2007·Granted Jun 23, 2009·0 cites·24 claims
- 1559US2019169274A1Human anti-tau antibodiesBIOGEN MA INC·Filed 2018·Application pending·0 cites
- 1658US2018002409A1Human Anti-Tau AntibodiesBIOGEN INT NEUROSCIENCE GMBH·Filed 2017·Application pending·0 cites
- 1757US2024287504A1Genomic library preparation and targeted epigenetic assays using cas-grna ribonucleoproteinsILLUMINA INC·Filed 2022·Application pending·0 cites
- 1855US2017369560A1Human anti-tau antibodiesBIOGEN MA INC·Filed 2017·Application pending·0 cites
- 1954US2005015819A1Method of inducing the formation of neurofibrillary tangles in transgenic animalsFiled 2002·Application pending·0 cites
- 2049US2010172919A1Noveltreatment for neurological disordersGRIMM JAN·Filed 2008·Application pending·0 cites
- 2139US2002077352A1N-methyl-D-aspartate receptor antagonistsFiled 2001·Application pending·0 cites
- 2231US12152070B2Medicinal composition containing monoclonal antibody or antibody fab fragment thereof, and use thereofOHEALTH BIOPHARMACEUTICAL SUZHOU CO LTD·Filed 2019·Granted Nov 26, 2024·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Feng Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →